What Is New in Biomarker Testing at Diagnosis of Advanced Non-Squamous Non-Small Cell Lung Carcinoma? Implications for Cytology and Liquid Biopsy

The discovery and clinical validation of biomarkers predictive of the response of non-squamous non-small-cell lung carcinomas (NS-NSCLC) to therapeutic strategies continue to provide new data. The evaluation of novel treatments is based on molecular analyses aimed at determining their efficacy. Thes...

Full description

Bibliographic Details
Main Author: Paul Hofman
Format: Article
Published: MDPI AG 2021-06-01
Series:Journal of Molecular Pathology
Online Access:https://www.mdpi.com/2673-5261/2/2/15